USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Growth Opportunities in the Western European IVD Industry, Forecast to 2021
Growth Opportunities in the Western European IVD Industry, Forecast to 2021
Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions
RELEASE DATE
23-Jun-2017
23-Jun-2017
REGION
Europe
Europe
Research Code: MD00-01-00-00-00
SKU: HC02835-EU-MR_20306
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02835-EU-MR_20306
Description
Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the self-monitoring blood glucose (SMBG) segment's growth in emerging markets is severely dampened by the slowing growth from reimbursement reductions in Western Europe.The broad applicability of POCT, combined with downward pricing trends enabled by microfluidics integration, supports the long-term growth of this segment. The Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Eastern European markets.
The recent success of companion diagnostic tests and personalised medicine is driving the uptake of various tests in an aim to save costs, thus opening up an opportunity to expand the test menus in existing installs. Diagnostic testing will continue to move towards process simplicity and decentralisation. IVD market participants are expected to employ a diverse set of strategies rather than rely on comprehensive product portfolios to grow their businesses. Companies are also gaining new market access through acquisitions, and this has intensified competition among tier 1 participants.
This study offers comprehensive information on every aspect of the IVD market. It is segmented into 8 subdivisions, namely, immunochemistry, POCT, SMBG, molecular diagnostics, clinical microbiology, haemostasis, hematology, and tissue diagnostics. Discussion on key trends and opportunities and company profile analysis by segment are also provided. In addition, there are dedicated country chapters for the key Western European markets (Germany, France, the United Kingdom, Spain, Italy, Benelux, and Scandinavia) and a snapshot of the regulatory policies awaiting to transform the industry.
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Western European IVD Market Dynamics
Key Trends Driving the Market
Strategic Imperatives for IVD Companies
8 Big Market Directions
Scope and Segmentation
Market Definition—Diagnostics for Health
IVD Value Chain across Patient Continuum
Segment Overview
How Do IVDs Reach Patients in Europe?
Major Regulatory Developments and Future Implications
Reimbursement Policies for IVD across Western Europe (EU5)
Stepping Stones that Promote IVD among the Public (with Government Backing)
Key Trend 1—Consolidation of Labs
Key Trend 2—Decentralized Laboratory Testing
Emerging Technology 1—Companion Diagnostics
Participants are Expanding Their Product Portfolios to Include Companion Diagnostics
Emerging Technology 2—Liquid Biopsy
Participants are Expanding Their Product Portfolios to Include Liquid Biopsy
Other Key Emerging Technologies
Regional Perspective
Market Analysis—Germany
Market Analysis—France
Market Analysis—Italy
Market Analysis—The United Kingdom
Market Analysis—Spain
Market Analysis—Benelux
Market Analysis—Scandinavia
Market Analysis—Rest of Europe
Market Analysis—Rest of Europe (Poland)
Market Drivers
Market Restraints
Growth Opportunity 1—Infectious Disease Diagnostics
Growth Opportunity 2—Data-driven Digital POCT
Growth Opportunity 3—Personalized Medicine through Companion Diagnostics and Pharmacogenomics
Growth Opportunity 4—Genetic Testing
Growth Opportunity 5—Geographical Expansion to Eastern Europe
Western European IVD Market by Segment
Western European IVD Market by Country
Western European IVD Market by Market Participants
Key Mergers, Acquisitions, and Partnership Assessment
Western European IVD Market—Revenue Forecast
Western European IVD Market—Segment Life Cycle Analysis
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
6Key Trends
Growth Opportunities
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
Segment Overview
Revenue Forecast
Snapshot of Key Participants
Market Share of Top Competitors
Key Trends
Growth Opportunities
Top Predictions for the Western European IVD Market
Legal Disclaimer
List of Figures- 1. IVD Market: Reimbursement Scenario, Western Europe, 2016
- 2. IVD Market: Healthcare Structure, Western Europe, 2016
- 3. IVD Market: Key Drivers, Western Europe, 2017–2021
- 4. IVD Market: Key Restraints, Western Europe, 2017–2021
- 5. IVD Market: Key M&A and Partnership Assessment, Western Europe, 2016
- 6. Immunochemistry Segment: Key Participants, Western Europe, 2016
- 7. Immunochemistry Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
- 8. Molecular Diagnostics Segment: Key Participants, Western Europe, 2016
- 9. Molecular Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
- 10. POCT Segment: Key Participants, Western Europe, 2016
- 11. POCT Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
- 12. Tissue Diagnostics Segment: Key Participants, Western Europe, 2016
- 13. Tissue Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
- 14. SMBG Segment: Key Participants, Western Europe, 2016
- 15. SMBG Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
- 16. Clinical Microbiology Segment: Key Participants, Western Europe, 2016
- 17. Clinical Microbiology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
- 18. Haemostasis Segment: Key Participants, Western Europe, 2016
- 19. Haematology Segment: Key Participants, Western Europe, 2016
- 20. Haematology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
List of Charts- 1. IVD Market: Technology Adoption, Western Europe, 2016
- 2. IVD Market: Percent Revenue Breakdown by Segment, Western Europe, 2016
- 3. IVD Market: Percent Revenue Breakdown by Country, Western Europe, 2016
- 4. IVD Market: Percent Revenue Breakdown, Western Europe, 2016
- 5. IVD Market: Revenue Forecast, Western Europe, 2016–2021
- 6. IVD Market: Segment Life Cycle Analysis, Western Europe, 2016
- 7. Immunochemistry Segment: Revenue Forecast, Western Europe, 2016–2021
- 8. Immunochemistry Segment: Percent Revenue Breakdown, Western Europe, 2016
- 9. Molecular Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021
- 10. Molecular Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016
- 11. POCT Segment: Revenue Forecast, Western Europe, 2016–2021
- 12. POCT Segment: Percent Revenue Breakdown, Western Europe, 2016
- 13. Tissue Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021
- 14. Tissue Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016
- 15. SMBG Segment: Revenue Forecast, Western Europe, 2016–2021
- 16. SMBG Segment: Percent Revenue Breakdown, Western Europe, 2016
- 17. Clinical Microbiology Segment: Revenue Forecast, Western Europe, 2016–2021
- 18. Clinical Microbiology Segment: Percent Revenue Breakdown, Western Europe, 2016
- 19. Haemostasis Segment: Revenue Forecast, Western Europe, 2016–2021
- 20. Haemostasis Segment: Percent Revenue Breakdown, Western Europe, 2016
- 21. Haemostasis Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021
- 22. Haematology Segment: Revenue Forecast, Western Europe, 2016–2021
- 23. Haematology Market: Percent Revenue Breakdown, Western Europe, 2016
Popular Topics
Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the self-monitoring blood glucose (SMBG) segment's growth in emerging markets is severely dampened by the slowing growth from reimbursement reductions in Western Europe.The broad applicability of POCT, combined with downward pricing trends enabled by microfluidics integration, supports the long-term growth of this segment. The Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Eastern European markets.
The recent success of companion diagnostic tests and personalised medicine is driving the uptake of various tests in an aim to save costs, thus opening up an opportunity to expand the test menus in existing installs. Diagnostic testing will continue to move towards process simplicity and decentralisation. IVD market participants are expected to employ a diverse set of strategies rather than rely on comprehensive product portfolios to grow their businesses. Companies are also gaining new market access through acquisitions, and this has intensified competition among tier 1 participants.
This study offers comprehensive information on every aspect of the IVD market. It is segmented into 8 subdivisions, namely, immunochemistry, POCT, SMBG, molecular diagnostics, clinical microbiology, haemostasis, hematology, and tissue diagnostics. Discussion on key trends and opportunities and company profile analysis by segment are also provided. In addition, there are dedicated country chapters for the key Western European markets (Germany, France, the United Kingdom, Spain, Italy, Benelux, and Scandinavia) and a snapshot of the regulatory policies awaiting to transform the industry.
| No Index | No |
|---|---|
| Podcast | No |
| Table of Contents | | Executive Summary~ || Western European IVD Market Dynamics~ || Key Trends Driving the Market~ || Strategic Imperatives for IVD Companies~ || 8 Big Market Directions~ || Scope and Segmentation~ | Market Overview~ || Market Definition—Diagnostics for Health~ || IVD Value Chain across Patient Continuum~ || Segment Overview~ | Market Dynamics—Western Europe~ || How Do IVDs Reach Patients in Europe?~ || Major Regulatory Developments and Future Implications~ || Reimbursement Policies for IVD across Western Europe (EU5)~ || Stepping Stones that Promote IVD among the Public (with Government Backing)~ | Trend Analysis—Western European IVD Market~ || Key Trend 1—Consolidation of Labs~ || Key Trend 2—Decentralized Laboratory Testing~ | Emerging Technologies in the Western European IVD Market~ || Emerging Technology 1—Companion Diagnostics~ || Participants are Expanding Their Product Portfolios to Include Companion Diagnostics~ || Emerging Technology 2—Liquid Biopsy~ || Participants are Expanding Their Product Portfolios to Include Liquid Biopsy~ || Other Key Emerging Technologies~ | Regional Analysis—Western Europe~ || Regional Perspective~ || Market Analysis—Germany~ || Market Analysis—France~ || Market Analysis—Italy~ || Market Analysis—The United Kingdom~ || Market Analysis—Spain~ || Market Analysis—Benelux~ || Market Analysis—Scandinavia~ || Market Analysis—Rest of Europe~ || Market Analysis—Rest of Europe (Poland)~ | Drivers and Restraints—IVD Market~ || Market Drivers~ || Market Restraints~ | Growth Opportunities and Companies to Action~ || Growth Opportunity 1—Infectious Disease Diagnostics~ || Growth Opportunity 2—Data-driven Digital POCT~ || Growth Opportunity 3—Personalized Medicine through Companion Diagnostics and Pharmacogenomics~ || Growth Opportunity 4—Genetic Testing~ || Growth Opportunity 5—Geographical Expansion to Eastern Europe~ | Revenue Forecast—IVD Market~ || Western European IVD Market by Segment~ || Western European IVD Market by Country~ || Western European IVD Market by Market Participants~ || Key Mergers, Acquisitions, and Partnership Assessment~ || Western European IVD Market—Revenue Forecast~ | Segment Analysis—IVD Market~ || Western European IVD Market—Segment Life Cycle Analysis~ | Immunochemistry Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Molecular Diagnostics Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | POCT Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Tissue Diagnostics Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Self-monitoring Blood Glucose Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Clinical Microbiology Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || 6Key Trends~ || Growth Opportunities~ | Haemostasis Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Haematology Segment Analysis~ || Segment Overview~ || Revenue Forecast~ || Snapshot of Key Participants~ || Market Share of Top Competitors~ || Key Trends~ || Growth Opportunities~ | Conclusion~ || Top Predictions for the Western European IVD Market~ || Legal Disclaimer~ | The Frost & Sullivan Story~ |
| List of Charts and Figures | 1. IVD Market: Reimbursement Scenario, Western Europe, 2016~ 2. IVD Market: Healthcare Structure, Western Europe, 2016~ 3. IVD Market: Key Drivers, Western Europe, 2017–2021~ 4. IVD Market: Key Restraints, Western Europe, 2017–2021~ 5. IVD Market: Key M&A and Partnership Assessment, Western Europe, 2016~ 6. Immunochemistry Segment: Key Participants, Western Europe, 2016~ 7. Immunochemistry Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 8. Molecular Diagnostics Segment: Key Participants, Western Europe, 2016~ 9. Molecular Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 10. POCT Segment: Key Participants, Western Europe, 2016~ 11. POCT Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 12. Tissue Diagnostics Segment: Key Participants, Western Europe, 2016~ 13. Tissue Diagnostics Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 14. SMBG Segment: Key Participants, Western Europe, 2016~ 15. SMBG Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 16. Clinical Microbiology Segment: Key Participants, Western Europe, 2016~ 17. Clinical Microbiology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 18. Haemostasis Segment: Key Participants, Western Europe, 2016~ 19. Haematology Segment: Key Participants, Western Europe, 2016~ 20. Haematology Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~| 1. IVD Market: Technology Adoption, Western Europe, 2016~ 2. IVD Market: Percent Revenue Breakdown by Segment, Western Europe, 2016~ 3. IVD Market: Percent Revenue Breakdown by Country, Western Europe, 2016~ 4. IVD Market: Percent Revenue Breakdown, Western Europe, 2016~ 5. IVD Market: Revenue Forecast, Western Europe, 2016–2021~ 6. IVD Market: Segment Life Cycle Analysis, Western Europe, 2016~ 7. Immunochemistry Segment: Revenue Forecast, Western Europe, 2016–2021~ 8. Immunochemistry Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 9. Molecular Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021~ 10. Molecular Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 11. POCT Segment: Revenue Forecast, Western Europe, 2016–2021~ 12. POCT Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 13. Tissue Diagnostics Segment: Revenue Forecast, Western Europe, 2016–2021~ 14. Tissue Diagnostics Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 15. SMBG Segment: Revenue Forecast, Western Europe, 2016–2021~ 16. SMBG Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 17. Clinical Microbiology Segment: Revenue Forecast, Western Europe, 2016–2021~ 18. Clinical Microbiology Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 19. Haemostasis Segment: Revenue Forecast, Western Europe, 2016–2021~ 20. Haemostasis Segment: Percent Revenue Breakdown, Western Europe, 2016 ~ 21. Haemostasis Segment: Top 3 Growth Opportunities, Western Europe, 2017–2021~ 22. Haematology Segment: Revenue Forecast, Western Europe, 2016–2021~ 23. Haematology Market: Percent Revenue Breakdown, Western Europe, 2016 ~ |
| Author | Saravanan Thangaraj |
| Industries | Healthcare |
| WIP Number | MD00-01-00-00-00 |
| Is Prebook | No |